Eosinophils: changing perspectives in health and disease - PubMed (original) (raw)

Review

Eosinophils: changing perspectives in health and disease

Helene F Rosenberg et al. Nat Rev Immunol. 2013 Jan.

Abstract

Eosinophils have been traditionally perceived as terminally differentiated cytotoxic effector cells. Recent studies have profoundly altered this simplistic view of eosinophils and their function. New insights into the molecular pathways that control the development, trafficking and degranulation of eosinophils have improved our understanding of the immunomodulatory functions of these cells and their roles in promoting homeostasis. Likewise, recent developments have generated a more sophisticated view of how eosinophils contribute to the pathogenesis of different diseases, including asthma and primary hypereosinophilic syndromes, and have also provided us with a more complete appreciation of the activities of these cells during parasitic infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1

Figure 1. The eosinophil.

a | Human eosinophils from peripheral blood stained with modified Giemsa exhibit characteristic bilobed nuclei and large red-stained cytoplasmic secretory granules. The cells with multilobed nuclei and without large granules are neutrophils. Original magnification, ×100. b | The image shows eosinophils and neutrophils isolated from the spleen of a _Cd2_-interleukin-5-transgenic mouse and stained with modified Giemsa. c | The image shows a transmission electron micrograph of a mouse eosinophil. Cytoplasmic secretory granules are indicated by the arrows; the central core of these granules contains cationic major basic protein, and their periphery contains the remaining major cationic proteins, cytokines, chemokines, growth factors and enzymes. Original magnification, ×6,000.

Figure 2

Figure 2. Cellular features of eosinophils.

Eosinophils are equipped with features that promote interactions with the environment. In one such interaction, eosinophils release the contents of their specific granules in response to external stimuli. Some of these granule contents are released via membrane-bound vesicles known as eosinophil sombrero vesicles. Eosinophils also synthesize lipid mediators for release in cytoplasmic lipid bodies and store Charcot–Leyden crystal protein (CLC) in primary granules. Although not highly biosynthetic, mature eosinophils have minimal numbers of mitochondria and a limited endoplasmic reticulum (ER) and Golgi, as well as a nucleus. Eosinophils express a wide variety of receptors that modulate adhesion, growth, survival, activation, migration and pattern recognition. Mouse eosinophils do not express CLC or Fcε receptor 1 (FcεR1) and have divergent homologues of sialic acid-binding immunoglobulin-like lectin 8 (SIGLEC-8) and the granule ribonucleases eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP). APRIL, a proliferation-inducing ligand; CCL, CC-chemokine ligand; CCR, CC-chemokine receptor; CXCL, CXC-chemokine ligand; CXCR, CXC-chemokine receptor; EGF, epidermal growth factor; EPX, eosinophil peroxidase; FPR1, formyl peptide receptor 1; GM-CSF, granulocyte–macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; MBP, major basic protein; NGF, nerve growth factor; NOD, nucleotide-binding oligomerization domain protein; PAR, proteinase-activated receptor; PDGF, platelet-derived growth factor; PIRB, paired immunoglobulin-like receptor B; PPARγ, peroxisome proliferator-activated receptor-γ; PRR, pattern-recognition receptor; PSGL1, P-selectin glycoprotein ligand 1; RAGE, receptor for advanced glycation end-products; RIG-I, retinoic acid-inducible gene I; TGF, transforming growth factor; TLR, Toll-like receptor; TNF, tumour necrosis factor; SCF, stem cell factor; VEGF, vascular endothelial growth factor.

Figure 3

Figure 3. Eosinophils modulate the function of other leukocytes.

Eosinophils not only respond to signals, but also have a definitive impact on the actions of other leukocytes. Eosinophils can express MHC class II and co-stimulatory molecules, process antigens and stimulate T cells to proliferate and produce cytokines in an antigen-specific manner. Furthermore, acting together with dendritic cells (DCs), eosinophils regulate the recruitment of T helper 2 (TH2) cells in response to allergen sensitization and challenge by producing CC-chemokine ligand 17 (CCL17) and CCL22 (Refs 40, 41). Eosinophils also prime B cells for antigen-specific IgM production and sustain long-lived plasma cells in mouse bone marrow via the production of a proliferation-inducing ligand (APRIL) and interleukin-6 (IL-6),. Eosinophils that are stimulated by CpG DNA induce DC maturation51. Indeed, the eosinophil granule protein eosinophil-derived neurotoxin (EDN) promotes the maturation and activation of DCs,. Major basic protein (MBP) released from eosinophils activates neutrophils, causing them to release superoxide and IL-8 and increase their expression of the cell-surface integrin complement receptor 3 (CR3). Eosinophils also maintain alternatively activated macrophages in adipose tissue by producing IL-4 and IL-13 (Ref. 50). The eosinophil granule proteins MBP, eosinophil cationic protein (ECP) and eosinophil peroxidase (EPX) activate mast cells, resulting in the release of histamine. Likewise, eosinophil-derived nerve growth factor (NGF) prolongs mast cell survival.

Comment in

Similar articles

Cited by

References

    1. Steinbach KH, et al. Estimation of kinetic parameters of neutrophilic, eosinophilic, and basophilic granulocytes in human blood. Blut. 1979;39:27–38. doi: 10.1007/BF01008072. - DOI - PubMed
    1. Lamousé-Smith ES, Furuta GT. Eosinophils in the gastrointestinal tract. Curr. Gastroenterol. Rep. 2006;8:390–395. doi: 10.1007/s11894-006-0024-6. - DOI - PubMed
    1. Hogan SP, et al. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy. 2008;38:709–750. doi: 10.1111/j.1365-2222.2008.02958.x. - DOI - PubMed
    1. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv. Immunol. 2009;101:81–121. doi: 10.1016/S0065-2776(08)01003-1. - DOI - PMC - PubMed
    1. Foster PS, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 2001;179:173–181. doi: 10.1034/j.1600-065X.2001.790117.x. - DOI - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources